Synthesis of Enantiopure tert-Alcohols
CH2CH2CH=C(CH3)2 + CCrHϫ2], 5.16 (d, 3JH,H = 10.5 Hz, 1 H, chromatography (SiO2; hexane/diethyl ether, 90:10) afforded (–)-3
3
OCH2CH=CHH(E)), 5.36 (d, JH,H = 17 Hz, 1 H, OCH2CH=
(249 mg, 85%) as a colourless oil. Enantiomeric excess was deter-
3
CHH(Z)), 5.42 (d, JH,H = 6.5 Hz, 1 H, CCrH), 5.87–6.00 ppm (m, mined by HPLC analysis (Chiralcel OB, n-hexane/iPrOH, 98:2,
2 H, OCH2CH=CH2 + CCrH). 13C NMR: δ = 17.6 [CH=
0.5 mL/min, UV 220 nm); (R)-enantiomer tr = 14.9 min (minor);
C(CH3)2 ϫ1], 20.4 (CH3Ar), 22.3 [CH2CH2CH=C(CH3)2], 24.6 (S)-enantiomer tr = 24.1 min (major): Ն 97% ee. [α]2D0 = –18 (c =
(CH=C(CH3)2 ϫ1), 25.7 (CCH3), 42.8 [CH2CH2CH=C(CH3)2], 1.00, CHCl ). IR (neat): ν = 3430 cm–1 (br., OH). H NMR: δ =
1
˜
3
63.2 (OCH2CH=CH2), 76.7 (OCCH3), 90.5, 90.7, 93.1, 94.1
(CCrHϫ4), 110.3 (CH3CCr), 114.5 (CCrC), 115.6 (CH=CH2), 123.6
1.49 [s, 3 H, C(CH3)2], 1.52 [s, 3 H, C(CH3)2], 1.65 (s, 3 H, CCH3),
1.76–2.03 [m, 5 H, CH2CH2CH=C(CH3)2 + CH2CH2CH=C-
3
[CH=C(CH3)2], 132.0 [CH=C(CH3)2], 135.1 (CH=CH2), (CH3)2 + OH], 2.34 (s, 3 H, CH3Ar), 5.09 [t, JH,H = 6.5 Hz, 1
233.6 ppm (COϫ3). MS (CI): m/z (%): 412 (2) [M + NH4]+, 337
H, CH2CH2CH=C(CH3)2], 7.15 (d, JH,H = 8 Hz, 2 H, CArHϫ2),
3
3
(100) [M
–
(CH2=CH–CH2–O)]+, 336 (30) [M 2CO]+. 7.31 ppm (d, JH,H = 8 Hz, 2 H, CArHϫ2). 13C NMR: δ = 17.6
–
C21H26CrO4 (394.12): calcd. C 63.95, H 6.64; found C 63.95, H
6.68.
[CH=C(CH3)2 ϫ1], 20.9 (CH3Ar), 23.0 [CH2CH2CH=C(CH3)2],
25.7 (CCH3), 30.7 [CH=C(CH3)2 ϫ1], 43.7 [CH2CH2CH=C-
(CH3)2], 74.9 (OCCH3), 124.2 [CH=C(CH3)2], 124.7, 128.8
(CArHϫ4), 132.1 [CH=C(CH3)2], 136.0, 144.9 ppm (CAr ϫ2). MS
(CI): m/z (%): 236 (1) [M + NH4]+, 219 (7) [M + H]+, 218 (39)
[M]+, 201 (100) [M – OH]+. C15H22O (218.17): calcd. C 82.52, H
10.16; found C 82.62, H 10.19.
(–)-(R)-[1-(2-Allyloxy-6-methylhept-5-en-2-yl)-4-methylbenzene]tri-
carbonylchromium(0) [(–)-13]: Complex (–)-13 was prepared from
(–)-12 (598 mg, 1.91 mmol) following the procedure described for
(+)-13. 60% yield, yellow crystals. [α]2D0 = –17 (c = 1.06, CHCl3);
all other analytical data were identical to those obtained for (+)-
13.
(+)-(R)-6-Methyl-2-p-tolylhept-5-en-2-ol [(+)-Gossonorol] [(+)-3]:
Alcohol (+)-3 was prepared from (+)-14 (100 mg, 0.39 mmol) fol-
lowing the procedure described for (–)-3. 78% yield, colourless oil;
ee Ͼ 99%. [α]2D0 = +15 (c = 1.00, CHCl3); all other analytical data
were identical to those obtained for (–)-3.
(–)-(S)-1-[2-(Allyloxy)-6-methylhept-5-en-2-yl]-4-methylbenzene
[(–)-14]: Complex (+)-13 (595 mg, 1.51 mmol) in diethyl ether (600
mL) was exposed to air and light for 24 h. The reaction mixture
was filtered through a pad of Celite® and rinsed with diethyl ether.
The solvent was removed in vacuo and the crude mixture was puri-
fied by column chromatography (SiO2; hexane/diethyl ether, 100:0–
98:2) to afford (–)-14 (355 mg, 91%) as a colourless oil. (The chro-
mium-contaminated Celite was packaged for disposal in a secure
(7S,10S)- and (7S,10R)-Boivinianin B 5: Dimethyldioxirane solution
in acetone (8.0 mL, 0.072 , 0.58 mmol) was added to a solution
of (–)-gossonorol (–)-3 (111 mg, 0.51 mmol) in acetone (2.5 mL)
and the mixture was stirred at room temperature for 15 min. After
removal of the acetone in vacuo, the paste remaining was dissolved
in dichloromethane (2 mL), and reduced to dryness in vacuo twice
and then dried under high vacuum. The crude mixture was dis-
solved in CDCl3 (2.5 mL) and a catalytic amount of p-toluenesul-
fonic acid monohydrate (1.4 mg, 0.007 mmol) was added. The mix-
ture was stirred for 15 min and then the solvent was removed in
vacuo. The mixture was dissolved in diethyl ether and filtered
through a short pad of alumina. After removal of the solvent in
vacuo, purification by column chromatography [SiO2; hexane/di-
ethyl ether, 100:0–90:10 (very slow gradient), then 90:10–70:30] af-
forded (7S,10S)-5 (32 mg, 27%), (7S,10R)-5 (13 mg, 11%) and a
landfill.) [α]2D0 = –1 (c = 1.00, CHCl ). IR (neat): ν = 1649 cm–1 (w,
˜
3
C=C). 1H NMR: δ = 1.53 [s, 3 H, C(CH3)2], 1.55 [s, 3 H, C-
(CH3)2], 1.65 (s, 3 H, OCCH3), 1.77–1.85 [m, 2 H, CH2CH2-
CH=C(CH3)2], 1.86–1.98 [m; 2 H, CH2CH2CH=C(CH3)2], 2.35 (s,
2
3
3 H, CH3Ar), 3.68 (dd, JH,H = 12.5, JH,H = 5 Hz, 1 H,
2
3
OCHHCH=CH2), 3.78 (dd, JH,H = 12.5, JH,H = 5 Hz, 1 H,
O C H H C H = C H 2 ) , 5 . 0 6 [ t , J H , H = 7 H z , 1 H ,
CH2 CH2 CH=C(CH3 )2 ], 5.13 (d, JH , H = 10.5 Hz, 1 H,
O C H 2 C H = C H H ( E ) ) , 5 . 3 2 ( d , J H , H = 1 7 H z , 1 H ,
3
3
3
3
OCH2CH=CHH(Z)), 5.92 (ddt, JH,H = 17, 10.5, 5 Hz, 1 H,
3
OCH2CH=CH2), 7.15 (d, JH,H = 8 Hz, 2 H, CArHϫ2), 7.28 ppm
(d, JH,H = 8 Hz, 2 H, CArHϫ2). 13C NMR: δ = 17.6 [CH=C-
3
mixture of both (43 mg, 36%) as colourless oils. IR (neat): ν = 3445
˜
(br., OH), 1099(s, C–O), 1078 cm–1 (s, C–O). MS (CI): m/z (%): 486
(6) [2M + NH4]+, 252 (100) [M + NH4]+, 235 (4) [M + H]+, 217
(90) [M – OH]+. C15H22O2 (234.16): calcd. C 76.88, H 9.46; found
C 76.78, H 9.35. (7S,10S)-5: Enantiomeric excess was determined
by HPLC analysis (Chiralcel OD-H, n-hexane/iPrOH, 98:2,
0.3 mL/min, UV 220 nm); (7R,10S)-enantiomer tr = 18.5 min
(minor); (7S,10S)-enantiomer tr = 21.3 min (major): Ն 97% ee, Ն
(CH3)2 ϫ 1], 21.0 (CH3Ar), 22.7 [CH2CH2CH=C(CH3)2], 23.9
[CH=C(CH3)2 ϫ1], 25.7 (CCH3), 42.6 [CH2CH2CH=C(CH3)2],
63.6 (OCH2CH=CH2), 78.9 (OCCH3), 115.4 (CH=CH2), 124.4
[CH=C(CH3)2], 126.0, 128.8 (CArH ϫ4), 131.3 [CH=C(CH3)2],
135.8 (CH=CH2), 136.2, 142.5 ppm (CAr ϫ2). MS (CI): m/z (%):
276 (1) [M + NH4]+, 218 (60) [M – (CH2CH=CH2) + H]+, 201
(100) [M – (OCH2CH=CH2)]+. C18H26O (258.20): calcd. C 83.67,
H 10.14; found C 83.62, H 10.17.
1
99% de. [α]2D0 = –10 (c = 1.01, CHCl3). H NMR: δ = 1.17 [s, 3 H,
C(CH3)2], 1.29 [s, 3 H, C(CH3)2], 1.50 (s, 3 H, CCH3), 1.62 (br. s,
1 H, OH), 1.70–1.79 (m, 1 H, CCH2CHHCHO), 1.84–1.94 (m, 1
H, CCH2CHHCHO), 2.00–2.07 (m, 1 H, CCHHCH2CHO), 2.19–
2.27 (m, 1 H, CCHHCH2CHO), 2.33 (s, 3 H, CH3Ar), 3.80 (appar-
(+)-(R)-1-[2-(Allyloxy)-6-methylhept-5-en-2-yl]-4-methylbenzene
[(+)-14]: Ether (+)-14 was prepared from (–)-19 (425 mg,
1.08 mmol) following the procedure described for (–)-14. 95%
yield, colourless oil. [α]2D0 = +1 (c = 1.01, CHCl3); all other analyti-
cal data were identical to those obtained for (–)-14.
3
3
ent t, JH,H = 7.5 Hz, 1 H, CH2CH2CHO), 7.14 (d, JH,H = 8 Hz,
3
2 H, CArHϫ2), 7.28 ppm (d, JH,H = 8 Hz, 2 H, CArHϫ2). 13C
(–)-(S)-6-Methyl-2-p-tolylhept-5-en-2-ol [(–)-Gossonorol] [(–)-3]: NMR: δ = 21.0 (CH3Ar), 24.2 [C(CH3)2], 26.5 (CCH2CH2CHO),
Ether (–)-14 (347 mg, 1.34 mmol) was dissolved in anhydrous meth-
anol (14 mL) and placed under a nitrogen atmosphere. Pd(PPh3)4
(77.7 mg, 0.067 mmol) was added and the resulting yellow solution
was stirred for 5 min before K2CO3 (558 mg, 4.03 mmol) was
added. The mixture was heated under reflux for 72 h. After cooling
to room temperature, the mixture was carefully neutralised with
1 HCl and extracted with dichloromethane (3ϫ100 mL). The
combined organic layers were washed with brine (100 mL), dried
with MgSO4 and concentrated in vacuo. Purification by column
27.3 [C(CH3)2], 30.6 (CCH3), 39.6 (CCH2CH2CHO), 71.1 (COH),
84.6 (CCH3), 85.4 (CHO), 124.6, 128.9 (CArHϫ4), 136.0
(CArCH3), 145.3 ppm (CArCO). (7S,10R)-5: Enantiomeric excess
was determined by HPLC analysis (Chiralcel OD-H, n-hexane/
iPrOH, 98:2, 0.3 mL/min, UV 220 nm); (7R,10R)-enantiomer tr =
20.0 min (minor); (7S,10R)-enantiomer tr = 20.7 min (major),
20
(7S,10S)-diastereomer tr = 21.3 min: Ն 97% ee, Ն 90% de. [α]
=
365
20
20
20
+5.1, [α] = +1.6, [α] = +0.7, [α] = +0.2 (c = 1.04, CHCl3).
436
546
578
1H NMR: δ = 1.12 [s, 3 H, C(CH3)2], 1.29 [s, 3 H, C(CH3)2], 1.48
Eur. J. Org. Chem. 2010, 2938–2944
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2943